Sangamo Therapeutics Inc (SGMO) — Cash Flow-to-Debt Ratio
Sangamo Therapeutics Inc (SGMO) has a Cash Flow-to-Debt Ratio of -0.35x as of September 2025, meaning its operating cash flow of $-28.50 Million could theoretically repay 0% of its total liabilities ($82.40 Million) in one year. See SGMO FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sangamo Therapeutics Inc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Sangamo Therapeutics Inc across 26 annual periods. Also explore SGMO shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sangamo Therapeutics Inc (1999–2024)
Year-by-year debt coverage analysis for Sangamo Therapeutics Inc. For market capitalisation and broader financial context, see Sangamo Therapeutics Inc (SGMO) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.85x | $-67.14 Million | $78.86 Million | ▲ +68.8% |
| 2023 | -2.73x | $-224.84 Million | $82.43 Million | ▼ -226.3% |
| 2022 | -0.84x | $-223.63 Million | $267.55 Million | ▼ -24.2% |
| 2021 | -0.67x | $-233.25 Million | $346.58 Million | ▼ -274.8% |
| 2020 | 0.39x | $169.88 Million | $441.18 Million | ▲ +154.6% |
| 2019 | -0.71x | $-144.40 Million | $204.78 Million | ▼ -524.9% |
| 2018 | 0.17x | $37.15 Million | $223.88 Million | ▲ +46.7% |
| 2017 | 0.11x | $11.18 Million | $98.84 Million | ▲ +103.7% |
| 2016 | -3.04x | $-65.88 Million | $21.70 Million | ▼ -123.3% |
| 2015 | -1.36x | $-33.72 Million | $24.80 Million | ▼ -776.5% |
| 2014 | -0.16x | $-5.67 Million | $36.58 Million | ▲ +84.8% |
| 2013 | -1.02x | $-19.48 Million | $19.13 Million | ▼ -122.3% |
| 2012 | -0.46x | $-8.08 Million | $17.64 Million | ▲ +87.3% |
| 2011 | -3.59x | $-25.89 Million | $7.20 Million | ▼ -6.5% |
| 2010 | -3.37x | $-23.93 Million | $7.09 Million | ▼ -761.0% |
| 2009 | -0.39x | $-6.14 Million | $15.66 Million | ▲ +71.9% |
| 2008 | -1.39x | $-17.34 Million | $12.45 Million | ▼ -2.1% |
| 2007 | -1.36x | $-16.07 Million | $11.78 Million | ▲ +33.3% |
| 2006 | -2.05x | $-14.48 Million | $7.08 Million | ▼ -461.7% |
| 2005 | -0.36x | $-4.07 Million | $11.17 Million | ▲ +91.6% |
| 2004 | -4.33x | $-10.16 Million | $2.35 Million | ▲ +8.6% |
| 2003 | -4.74x | $-7.44 Million | $1.57 Million | ▲ +3.0% |
| 2002 | -4.88x | $-9.67 Million | $1.98 Million | ▼ -113.3% |
| 2001 | -2.29x | $-6.11 Million | $2.67 Million | ▼ -89.8% |
| 2000 | -1.21x | $-2.45 Million | $2.04 Million | ▲ +34.7% |
| 1999 | -1.85x | $-2.40 Million | $1.30 Million | — |